When was SMi founded?

SMi was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is SMi located?

SMi is headquartered in Suffolk, United Kingdom. It is registered at 23 LONGMEADOW,LODE,CAMBRIDGE,UNITED KINGDOM,CB25 9HA.

Is SMi a funded company?

SMi is a funded company, having raised a total of $4.58M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 14, 2023.

When was the latest funding round of SMi?

SMi's latest funding was a $***** Seed round on Jun 14, 2023, with participation from 1 investor.

Where does SMi rank among its competitors?

SMi ranks 15th amongst 220 active competitors, of which 33 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was MedPrime Technologies, which secured $1.31M in Sep, 2024.

Who are the top competitors of SMi?

SMi's top competitors include Oxford Instruments, Olympus and ONI. Among them, MedPrime Technologies secured the most recent funding round in September, 2024.

SMi - 2026 Company Profile, Team, Funding, Competitors & Financials

SMi is a seed company based in Suffolk (United Kingdom), founded in 2018 by James Clark and Andrew Thompson. It operates as a Developer of a single molecule imaging tool for research and clinical diagnostics. SMi has raised $4.58M in funding. The company has 220 active competitors, including 33 funded and 44 that have exited. Its top competitors include companies like Oxford Instruments, Olympus and ONI.

Company Details

Developer of a single molecule imaging tool for research and clinical diagnostics. It offers optical technology-based diagnostic device for detecting single molecules that are associated with infectious and non-infectious diseases and a microscope to facilitate the detection of interactions between a therapeutic target and the antibodies or small molecule drugs.

Website: smisystems.co.uk
Email ID: *****@smisystems.co.uk
Registered Address: 23 LONGMEADOW,LODE,CAMBRIDGE,UNITED KINGDOM,CB25 9HA

Key Metrics

Founded Year

2018

Location

Suffolk, United Kingdom

Stage

Seed

Total Funding

$4.58M in 2 rounds

Latest Funding Round

Seed, Jun 14, 2023, $*****

Investors

Norcliffe Capital & 1 more

Ranked

15^th among 220 active competitors

Similar Companies

Olympus & 213 more

View SMi's full profile

SMi is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Smi Drug Discovery Limited CIN: 11175710 , United Kingdom, Active	Jan 28, 2018	-	13 (As on Dec 31, 2024)

SMi has raised a total funding of $4.58M over 2 rounds. Its first funding round was on Jun 14, 2023. Its latest funding round was a Seed round on Jun 14, 2023 for $*****. 1 investor participated in its latest round. SMi has 2 institutional investors.

Here is the list of recent funding rounds of SMi:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 14, 2023	7207233	Seed	6670556	4874442	7704854	9929628
Jun 14, 2023	1514390	Grant (prize money)	9467040	8036919	1694945	Ukri

Access funding benchmarks and valuations. Sign up today!

View details of SMi's funding rounds and investors

The founders of SMi are James Clark and Andrew Thompson.

Here are the details of SMi's key team members:

James Clark: Co-Founder & CFO of SMi.
Andrew Thompson: Founder & Director of SMi.

View details of SMi's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SMi include Oxford Instruments, Olympus and ONI. Here is the list of Top 10 competitors of SMi, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oxford Instruments 1959, High Wycombe (United Kingdom), Public	Developer of technology tools and systems for research and industry	-	Europa	70/100
2nd	Olympus 1919, Tokyo (Japan), Public	Manufacturer of imaging and surgical products	-	ValueAct Capital, Sony	68/100
3rd	ONI 2016, Oxford (United Kingdom), Series B	Manufacturer of optical microscopy solutions for biological imaging	$113M	Casdin Capital, Arch Venture Partners & 21 others	65/100
4th	M Squared 2006, Glasgow (United Kingdom), Series B	Developer of light-sheet microscopy systems for multiple business verticals	$30.7M	BGF, Barclays & 9 others	61/100
5th	Nicoya Life 2012, Kitchener (Canada), Series A	Provider of hyperspectral optical microscopes for surface analysis	$35M	Whitecap Venture Partners, Golden Triangle Angel Network ... & 19 others	59/100
6th	FEI Company 1971, Hillsboro (United States), Acquired	Electron microscopy solutions for advancing scientific discovery and industrial innovation	$300K	Starboard Capital Partners, Reference Capital Management ... & 2 others	59/100
7th	Park Systems 1997, Suwon-si (South Korea), Public	Manufacturer of atomic force microscopy and metrology instrumentation and solutions	-	JAFCO Asia	56/100
8th	MedPrime Technologies 2014, Thane (India), Seed	Developer of digital microscopes for pathology and telepathology	$1.71M	SINE, RiSo Capital & 24 others	53/100
9th	Raith 1980, Dortmund (Germany), Funding Raised	Provider of nanofabrication systems and characterization solutions for industry and academia	-	Hannover Finanz, Europa	49/100
10th	Phase Focus 2006, Sheffield (United Kingdom), Acquired	Provider of virtual lens that generates High definition images without high-quality lenses	$12.1M	Braveheart Investment Group, Ombu Group & 11 others	47/100
15th	SMi 2018, Suffolk (United Kingdom), Seed	Developer of a single molecule imaging tool for research and clinical diagnostics	$4.58M	Norcliffe Capital, Ukri	46/100